LY334370 is a novel and potent 5-HT1F receptor agonist.

Cyamemazine (Tercian; Cianatil; cyamepromazine) is a typical antipsychotic drug of the phenothiazine class.

Fananserin (RP-62203; RP62203) is a novel and potent antipsychotic agent acting as a 5-hydroxytryptamine2 (5-HT2) receptor antagonist (Ki = 0.37 nM for the rat 5-HT2A receptor).

TG6-10-1 is a cell-permeable, highly potent, selective, and competitive antagonist of prostaglandin E2 receptor (EP2) with Kb of 17.8 nM.

VUF10166 (VUF-10166; VUF 10166) is a novel, potent and competitive antagonist against serotonin 5-HT3A receptor with important biological activity.

YL-0919 is a novel, potent and orally bioactive antidepressant acting as 5-HT1A receptor agonist (Ki=0.19 nM) and selective serotonin reuptake inhibitor.

Vilazodone HCl (SB659746A; SB659746-A; EMD-68843; EMD68843; Viibryd), the hydrochloride salt of Vilazodone, is a selective serotonin reuptake inhibitor (SSRI) and a partial agonist of 5-HT1A receptors with anti-depressive effects.

Granisetron HCl (BRL-43694; BRL43694; BRL-43694A; trade name: Kytril), an approved antiemetic drug, is a potent serotonin 5-HT3 receptor antagonist with antiemetic activity.

Piboserod (SB 207266; trade name Serlipet) is a novel, potent and selective 5-HT(4) receptor antagonist marketed by GSK.

Cisapride (formerly R51619; R 51619; R-51619; Kaudalit; Prepulsid; Kinestase; Pridesia; Presid; Propulsid) is a benzamide-based nonselective agonist of serotonin 5-HT4 receptor.